Utility of Intersystem Extrapolation Factors in Early Reaction Phenotyping and the Quantitative Extrapolation of Human Liver Microsomal Intrinsic Clearance Using Recombinant Cytochromes P450 Publication Utility of Intersystem Extrapolation Factors in Early Reaction Phenotyping and the Quantitative Extrapolation of Human Liver Microsomal Intrinsic Clearance Using Recombinant Cytochromes P450 Reaction phenotyping using recombinant human cytochromes P450 (P450) has great utility in early discovery. However,…CertaraMarch 1, 2011
Casopitant: In Vitro Data and Simcyp Simulation to Predict In Vivo Metabolic Interactions Involving Cytochrome P450 3A4 Publication Casopitant: In Vitro Data and Simcyp Simulation to Predict In Vivo Metabolic Interactions Involving Cytochrome P450 3A4 has previously been shown to be a potent and selective antagonist of the human neurokinin-1…CertaraMarch 1, 2011
Modeling and Predicting Drug Pharmacokinetics in Patients with Renal Impairment Publication Modeling and Predicting Drug Pharmacokinetics in Patients with Renal Impairment Current guidance issued by the US FDA to assess the impact of renal impairment on…CertaraMarch 1, 2011
Resurgence in the Use of Physiologically-based Pharmacokinetic Models in Pediatric Clinical Pharmacology: Parallel Shift in Incorporating the Knowledge of Biological Elements and Increased Applicability to Drug Development and Clinical Practice Publication Resurgence in the Use of Physiologically-based Pharmacokinetic Models in Pediatric Clinical Pharmacology: Parallel Shift in Incorporating the Knowledge of Biological Elements and Increased Applicability to Drug Development and Clinical Practice This study had two primary aims: (i) To describe an example of the development work…CertaraMarch 1, 2011
Blood or Plasma? Which Should You Assay for Drug Concentration? Knowledge Base Blood or Plasma? Which Should You Assay for Drug Concentration? Explore blood vs. plasma drug concentration assays. Learn their differences, relationships, and impact on accurate…CertaraFebruary 19, 2011
Why Should You Evaluate Dose Proportionality? BlogKnowledge Base Why Should You Evaluate Dose Proportionality? Dose proportionality is a common phrase used pharmacokinetics. Early in the pre-clinical development process, we…CertaraFebruary 17, 2011
What is the Difference Between PK and TK? Knowledge Base What is the Difference Between PK and TK? Explore the key differences between pharmacokinetics (PK) and toxicokinetics (TK), their roles in drug development,…CertaraFebruary 15, 2011
Why are PK Parameters Lognormally Distributed? Knowledge Base Why are PK Parameters Lognormally Distributed? The statistical analysis of pharmacokinetic parameters is often overlooked and not always well understood. The…CertaraFebruary 10, 2011
What are Direct and Indirect Pharmacodynamic Models? Knowledge Base What are Direct and Indirect Pharmacodynamic Models? When constructing pharmacodynamic (PD) models, you will often encounter the adjectives “direct” and “indirect” describing…CertaraFebruary 8, 2011
What is Modeling and Simulation? Knowledge Base What is Modeling and Simulation? I am currently attending a short conference on modeling and simulation in pediatric clinical pharmacology,…CertaraFebruary 1, 2011